Viking Therapeutics Inc (VKTX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: VKTX Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-03 2024-05-03 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
847 -0.5%
76.07
64,435 USD 		847 -0.5% 76.07 64,435 USD
2024-05-03 2024-05-03 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
17,238 -8.9%
75.49
1,301,241 USD 		17,238 -8.9% 75.49 1,301,241 USD
2024-05-03 2024-05-03 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
45,570 -19.1%
74.44
3,392,445 USD 		45,570 -19.1% 74.44 3,392,445 USD
2024-05-03 2024-05-03 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
3,101 -1.3%
73.49
227,887 USD 		3,101 -1.3% 73.49 227,887 USD
2024-05-02 2024-05-01 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
6,248 -1.8%
80.08
500,310 USD 		6,248 -1.8% 80.08 500,310 USD
2024-05-02 2024-05-01 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
119,946 -25.3%
79.29
9,511,058 USD 		119,946 -25.3% 79.29 9,511,058 USD
2024-05-02 2024-05-01 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
105,343 -18.2%
78.65
8,284,974 USD 		105,343 -18.2% 78.65 8,284,974 USD
2024-05-02 2024-05-01 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
26,142 -4.3%
77.49
2,025,830 USD 		26,142 -4.3% 77.49 2,025,830 USD
2024-05-02 2024-05-01 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
23,746 -3.8%
76.40
1,814,301 USD 		23,746 -3.8% 76.40 1,814,301 USD
2024-02-09 2024-02-09 PS Planned sale

Lian Brian

President & CEO

Executive Director
45,000 -2.1%
29.90
1,345,500 USD 		45,000 -2.1% 29.90 1,345,500 USD
2024-02-08 2024-02-08 PS Planned sale

Rouan Sarah Kathryn

Non-Executive Director
25,000 -100.0%
28.05
701,250 USD 		25,000 -100.0% 28.05 701,250 USD
2024-02-08 2024-02-08 PS Planned sale

Lian Brian

President & CEO

Executive Director
40,000 -1.8%
28.90
1,156,000 USD 		40,000 -1.8% 28.90 1,156,000 USD
2024-02-08 2024-02-08 PS Planned sale

Lian Brian

President & CEO

Executive Director
40,000 -1.8%
27.45
1,098,000 USD 		40,000 -1.8% 27.45 1,098,000 USD
2024-02-08 2024-02-08 PS Planned sale

Lian Brian

President & CEO

Executive Director
80,000 -3.4%
26.95
2,156,000 USD 		80,000 -3.4% 26.95 2,156,000 USD
2024-02-08 2024-02-08 PS Planned sale

Lian Brian

President & CEO

Executive Director
60,000 -2.5%
25.95
1,557,000 USD 		60,000 -2.5% 25.95 1,557,000 USD
2024-02-08 2024-02-08 PS Planned sale

Lian Brian

President & CEO

Executive Director
49,079 -2.1%
25.75
1,263,784 USD 		49,079 -2.1% 25.75 1,263,784 USD
2024-01-31 2024-01-31 PS Planned sale

Lian Brian

President & CEO

Executive Director
45,000 -1.9%
24.95
1,122,750 USD 		45,000 -1.9% 24.95 1,122,750 USD
2024-01-31 2024-01-31 PS Planned sale

Lian Brian

President & CEO

Executive Director
40,000 -1.7%
24.45
978,000 USD 		40,000 -1.7% 24.45 978,000 USD
2024-01-30 2024-01-30 PS Planned sale

Lian Brian

President & CEO

Executive Director
35,000 -1.5%
23.95
838,250 USD 		35,000 -1.5% 23.95 838,250 USD
2024-01-19 2024-01-19 PS Planned sale

Rouan Sarah Kathryn

Non-Executive Director
30,000 -100.0%
23.05
691,500 USD 		30,000 -100.0% 23.05 691,500 USD
2024-01-04 2024-01-04 S Sale

ZANTE GREG

Chief Financial Officer

Officer
15,000 -7.7%
17.90
268,500 USD 		15,000 -7.7% 17.90 268,500 USD
2023-05-18 2023-05-16 PS Planned sale

MACARTNEY LAWSON

Non-Executive Director
16,000 -25.0%
24.00
384,000 USD 		16,000 -25.0% 24.00 384,000 USD
2023-05-18 2023-05-16 PS Planned sale

Rowland Charles A Jr

Non-Executive Director
40,000 -57.1%
25.00
1,000,000 USD 		40,000 -57.1% 25.00 1,000,000 USD
2023-05-01 2023-05-01 PS Planned sale

Lian Brian

President & CEO

Executive Director
45,000 -2.0%
22.45
1,010,250 USD 		45,000 -2.0% 22.45 1,010,250 USD
2023-04-24 2023-04-24 PS Planned sale

MACARTNEY LAWSON

Non-Executive Director
16,000 -25.0%
22.00
352,061 USD 		16,000 -25.0% 22.00 352,061 USD
2023-04-21 2023-04-19 PS Planned sale

Lian Brian

President & CEO

Executive Director
35,000 -1.5%
21.45
750,750 USD 		35,000 -1.5% 21.45 750,750 USD
2023-04-18 2023-04-17 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
7,500 -4.8%
20.00
150,000 USD 		7,500 -4.8% 20.00 150,000 USD
2023-04-18 2023-04-17 PS Planned sale

MACARTNEY LAWSON

Non-Executive Director
20,786 -30.2%
20.00
415,720 USD 		20,786 -30.2% 20.00 415,720 USD
2023-04-18 2023-04-17 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
12,500 -4.2%
20.00
250,000 USD 		12,500 -4.2% 20.00 250,000 USD
2023-04-18 2023-04-17 PS Planned sale

Lian Brian

President & CEO

Executive Director
155,000 -6.4%
20.45
3,169,766 USD 		155,000 -6.4% 20.45 3,169,766 USD
2023-04-13 2023-04-13 PS Planned sale

Lian Brian

President & CEO

Executive Director
79,336 -3.3%
18.45
1,463,749 USD 		79,336 -3.3% 18.45 1,463,749 USD
2023-04-13 2023-04-12 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
41,544 -21.8%
18.00
747,792 USD 		41,544 -21.8% 18.00 747,792 USD
2023-04-13 2023-04-11 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
56,295 -27.4%
18.00
1,013,518 USD 		56,295 -27.4% 18.00 1,013,518 USD
2023-04-03 2023-04-03 PS Planned sale

Lian Brian

President & CEO

Executive Director
22,000 -1.0%
17.85
392,700 USD 		22,000 -1.0% 17.85 392,700 USD
2023-04-03 2023-04-03 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
30,911 -17.3%
18.00
556,398 USD 		30,911 -17.3% 18.00 556,398 USD
2023-04-03 2023-03-31 PS Planned sale

Lian Brian

President & CEO

Executive Director
67,970 -2.9%
17.45
1,186,077 USD 		67,970 -2.9% 17.45 1,186,077 USD
2023-04-03 2023-03-30 PS Planned sale

Lian Brian

President & CEO

Executive Director
65,382 -2.8%
17.45
1,140,916 USD 		65,382 -2.8% 17.45 1,140,916 USD
2023-04-03 2023-03-30 PS Planned sale

Lian Brian

President & CEO

Executive Director
88,000 -3.7%
16.95
1,491,600 USD 		88,000 -3.7% 16.95 1,491,600 USD
2023-04-03 2023-03-30 PS Planned sale

ZANTE GREG

Chief Financial Officer

Officer
131,029 -47.0%
17.00
2,227,821 USD 		131,029 -47.0% 17.00 2,227,821 USD
2023-03-30 2023-03-29 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
41,242 -13.6%
16.00
659,872 USD 		41,242 -13.6% 16.00 659,872 USD
2023-03-30 2023-03-28 PS Planned sale

Mancini Marianna

Chief Operating Officer

Officer
196,563 -40.6%
15.00
2,948,445 USD 		196,563 -40.6% 15.00 2,948,445 USD
2022-05-03 2022-05-02 B Purchase

FOEHR MATTHEW W

Non-Executive Director
45,000 +67.9%
2.47
111,195 USD 		45,000 +67.9% 2.47 111,195 USD
2021-06-10 2021-06-10 B Purchase

FOEHR MATTHEW W

Non-Executive Director
20,000 +43.2%
5.69
113,800 USD 		20,000 +43.2% 5.69 113,800 USD
2020-08-27 2020-08-26 S Sale

LIGAND PHARMACEUTICALS INC

Large shareholder
94,488 -1.6%
8.11
766,109 USD 		94,488 -1.6% 8.11 766,109 USD
2020-08-27 2020-08-25 S Sale

LIGAND PHARMACEUTICALS INC

Large shareholder
70,000 -1.2%
8.02
561,575 USD 		70,000 -1.2% 8.02 561,575 USD
2018-09-27 2018-09-25 S Sale

LIGAND PHARMACEUTICALS INC

Large shareholder
262,881 -4.2%
19.15
5,034,250 USD 		262,881 -4.2% 19.15 5,034,250 USD
2018-05-31 2018-05-31 PS Planned sale

MORNEAU MICHAEL

VP, Finance and Administration

Officer
21,551 -18.6%
9.25
199,347 USD 		21,551 -18.6% 9.25 199,347 USD
2018-05-31 2018-05-31 B Purchase

SINGLETON J MATTHEW

Non-Executive Director
9,500 +inf%
9.82
93,261 USD 		9,500 +inf% 9.82 93,261 USD
2018-05-31 2018-05-29 B Purchase

Rowland Charles A Jr

Non-Executive Director
30,000 +inf%
5.16
154,800 USD 		30,000 +inf% 5.16 154,800 USD
2018-05-31 2018-05-29 B Purchase

MACARTNEY LAWSON

Non-Executive Director
47,965 +inf%
5.22
250,329 USD 		47,965 +inf% 5.22 250,329 USD
2018-05-31 2018-05-29 B Purchase

Webster Stephen W

Non-Executive Director
8,000 +inf%
5.21
41,712 USD 		8,000 +inf% 5.21 41,712 USD
2016-11-15 2016-11-15 B Purchase

FOEHR MATTHEW W

Non-Executive Director
13,000 +49.5%
1.21
15,678 USD 		13,000 +49.5% 1.21 15,678 USD
2016-04-13 2016-04-13 B Purchase

FOEHR MATTHEW W

Non-Executive Director
20,000 +320.0%
1.24
24,800 USD 		20,000 +320.0% 1.24 24,800 USD
2015-05-05 2015-05-04 B Purchase

FOEHR MATTHEW W

Non-Executive Director
6,250 +inf%
8.00
50,000 USD 		6,250 +inf% 8.00 50,000 USD